{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:09:18Z","timestamp":1784117358420,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2024-I2M-C"],"award-info":[{"award-number":["2024-I2M-C"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["T-B-069"],"award-info":[{"award-number":["T-B-069"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z221100003522002"],"award-info":[{"award-number":["Z221100003522002"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF0705004"],"award-info":[{"award-number":["2022YFF0705004"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFF0613304"],"award-info":[{"award-number":["2023YFF0613304"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFE0103600"],"award-info":[{"award-number":["2022YFE0103600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.modpat.2026.101017","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:57:09Z","timestamp":1779433029000},"page":"101017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiomics Integration Identifies a Molecular Subtype of Intrahepatic Cholangiocarcinoma With Enhanced Benefit From Adjuvant Therapy"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5076-2965","authenticated-orcid":false,"given":"Zhuo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2026.101017_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.modpat.2026.101017_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.modpat.2026.101017_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2026.101017_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221128689","article-title":"Cholangiocarcinoma: molecular abnormalities and cells of origin","volume":"22","author":"Testa","year":"2023","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.modpat.2026.101017_bib5","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.14218\/JCTH.2023.00118","article-title":"Expert consensus on pathological diagnosis of intrahepatic cholangiocarcinoma (2022 version)","volume":"11","author":"Wang","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.modpat.2026.101017_bib6","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1634\/theoncologist.2012-0432","article-title":"Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues","volume":"17","author":"Zhu","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.modpat.2026.101017_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.21037\/hbsn.2019.06.12","article-title":"Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus?","volume":"9","author":"Altman","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.modpat.2026.101017_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004892","article-title":"Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities","volume":"10","author":"Lin","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.modpat.2026.101017_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1158\/2326-6066.CIR-21-1101","article-title":"Molecular subgroups of intrahepatic cholangiocarcinoma discovered by single-cell RNA sequencing-assisted multiomics analysis","volume":"10","author":"Bao","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.modpat.2026.101017_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2026.101017_bib11","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","article-title":"MOVICS : an R package for multi-omics integration and visualization in cancer subtyping","volume":"36","author":"Lu","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.modpat.2026.101017_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/biostatistics\/kxx017","article-title":"A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data","volume":"19","author":"Mo","year":"2018","journal-title":"Biostatistics"},{"key":"10.1016\/j.modpat.2026.101017_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/acs.jproteome.5b00824","article-title":"moCluster: Identifying joint patterns across multiple omics data sets","volume":"15","author":"Meng","year":"2016","journal-title":"J Proteome Res"},{"key":"10.1016\/j.modpat.2026.101017_bib14","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1038\/s41467-018-06921-8","article-title":"Multi-omic tumor data reveal diversity of molecular mechanisms that correlate with survival","volume":"9","author":"Ramazzotti","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2026.101017_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176278","article-title":"Integrative clustering of multi-level \u2018omic data based on non-negative matrix factorization algorithm","volume":"12","author":"Chalise","year":"2017","journal-title":"PLOS One"},{"key":"10.1016\/j.modpat.2026.101017_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1023949509487","article-title":"Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data","volume":"52","author":"Monti","year":"2003","journal-title":"Mach Learn"},{"key":"10.1016\/j.modpat.2026.101017_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","article-title":"Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin","volume":"158","author":"Hoadley","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.modpat.2026.101017_bib18","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1093\/bioinformatics\/btz058","article-title":"NEMO: cancer subtyping by integration of partial multi-omic data","volume":"35","author":"Rappoport","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.modpat.2026.101017_bib19","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/bioinformatics\/bty1049","article-title":"PINSPlus: a tool for tumor subtype discovery in integrated genomic data","volume":"35","author":"Nguyen","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.modpat.2026.101017_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nmeth.2810","article-title":"Similarity network fusion for aggregating data types on a genomic scale","volume":"11","author":"Wang","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.modpat.2026.101017_bib21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1186\/s12864-015-2223-8","article-title":"Fast dimension reduction and integrative clustering of multi-omics data using low-rank approximation: application to cancer molecular classification","volume":"16","author":"Wu","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.modpat.2026.101017_bib22","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"10.1016\/j.modpat.2026.101017_bib23","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.modpat.2026.101017_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.modpat.2026.101017_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.15","article-title":"ImmPort, toward repurposing of open access immunological assay data for translational and clinical research","volume":"5","author":"Bhattacharya","year":"2018","journal-title":"Sci Data"},{"key":"10.1016\/j.modpat.2026.101017_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.231","article-title":"TCellSI: a novel method for T cell state assessment and its applications in immune environment prediction","volume":"3","author":"Yang","year":"2024","journal-title":"Imeta"},{"key":"10.1016\/j.modpat.2026.101017_bib27","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.modpat.2026.101017_bib28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.pathol.2023.07.008","article-title":"Role of immunophenotypic characterisation in prognostic subtyping of intrahepatic cholangiocarcinoma","volume":"55","author":"Li","year":"2023","journal-title":"Pathology"},{"key":"10.1016\/j.modpat.2026.101017_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-4598-5-10","article-title":"Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium","volume":"5","author":"Babu","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1016\/j.modpat.2026.101017_bib30","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.3748\/wjg.v11.i32.4939","article-title":"MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma","volume":"11","author":"Boonla","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.modpat.2026.101017_bib31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jtho.2023.12.015","article-title":"Outcome of first-line treatment with pembrolizumab according to KRAS\/TP53 mutational status for nonsquamous programmed death-ligand 1-high (\u226550%) NSCLC in the German National Network Genomic Medicine Lung Cancer","volume":"19","author":"Bischoff","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.modpat.2026.101017_bib32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jdi.13541","article-title":"T helper 17 cells: a new actor on the stage of type 2 diabetes and aging?","volume":"12","author":"Chang","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.modpat.2026.101017_bib33","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82217","article-title":"T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance","volume":"12","author":"Gao","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.modpat.2026.101017_bib34","first-page":"649","article-title":"Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact","volume":"22","author":"Park","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.modpat.2026.101017_bib35","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.7150\/jca.63235","article-title":"Mucin 1 promotes tumor progression through activating WNT\/\u03b2-catenin signaling pathway in intrahepatic cholangiocarcinoma","volume":"12","author":"Song","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.modpat.2026.101017_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.21037\/jgo-2024-925","article-title":"Claudin 18 immunohistochemistry in cholangiocarcinoma","volume":"16","author":"Desai","year":"2025","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.modpat.2026.101017_bib37","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.modpat.2026.101017_bib38","volume":"41","author":"Shitara","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.modpat.2026.101017_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2559.2006.02414.x","article-title":"Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour","volume":"49","author":"Aishima","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2026.101017_bib40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/liv.14090","article-title":"Diagnostic and prognostic biomarkers in cholangiocarcinoma","volume":"39","author":"Macias","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.modpat.2026.101017_bib41","article-title":"Isocitrate dehydrogenase mutations in cholangiocarcinoma: still a long road ahead","volume":"6","author":"Nichetti","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.modpat.2026.101017_bib42","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","article-title":"Breast cancer molecular subtypes respond differently to preoperative chemotherapy","volume":"11","author":"Rouzier","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101017_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.modpat.2026.101017_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103706","article-title":"Evolving therapeutic landscape of advanced biliary tract cancer: from chemotherapy to molecular targets","volume":"9","author":"Kehmann","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.modpat.2026.101017_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101936","article-title":"Current standards and future perspectives in adjuvant treatment for biliary tract cancers","volume":"84","author":"Lamarca","year":"2020","journal-title":"Cancer Treat Rev"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:22:23Z","timestamp":1784114543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0893395226000608"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101017","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiomics Integration Identifies a Molecular Subtype of Intrahepatic Cholangiocarcinoma With Enhanced Benefit From Adjuvant Therapy","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101017"}}